insomnia

The use of cognitive-behavioral therapy interventions, such as Big Health’s Sleepio program, has been found to improve both sleep and mental health in individuals with insomnia and clinically significant depressive symptoms, according to new research published in the Journal of Sleep Research.

Somryst, a prescription digital therapeutic combining cognitive behavioral therapy and personalized sleep restriction, is the first software product to put the FDA's early Precertification Program framework through its paces. 

Among a study group of 1,711 users, use of the Sleepio app appeared to drive improvements in self-reported functional health, psychological wellbeing, and sleep-related quality of life.

Physicians have touted the benefits of a good night’s sleep for centuries, if not longer, but it hasn’t been until recent years that a provider can see clear data on whether or not their patients have been hitting the sack.

ResMed, a medical device company focused on sleep apnea, has launched its first consumer product, a $149 device for tracking and improving sleep called S+.